{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:12:18Z","timestamp":1761765138744,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.purol.2009.02.006","type":"journal-article","created":{"date-parts":[[2009,4,5]],"date-time":"2009-04-05T03:44:27Z","timestamp":1238903067000},"page":"372-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Crit\u00e8res de d\u00e9cision et recommandations de bonne pratique clinique pour la premi\u00e8re injection intrad\u00e9trusorienne de toxine botulique A dans le traitement de l\u2019hyperactivit\u00e9 neurog\u00e8ne du d\u00e9trusor"],"prefix":"10.1016","volume":"19","author":[{"given":"B.","family":"Perrouin-Verbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ruffion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Gam\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Denys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kerdraon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Karsenty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"de S\u00e8ze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Haab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Saussine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Amarenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Chartier-Kastler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2009.02.006_bib1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib3","first-page":"79","article-title":"New therapeutic options for refractory neurogenic detrusor overactivity","volume":"56","author":"Giannantoni","year":"2004","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.purol.2009.02.006_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","article-title":"Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a european consensus report","volume":"55","author":"Apostolidis","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A intradetrusor injections in adults with neurogenic detrusor overactivity\/overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.annrmp.2008.03.003","article-title":"Suivi des patients apr\u00e8s injection de toxine botulique intradetrusorienne\u00a0; recommandations de bonne pratique clinique chez le patient neurologique","volume":"51","author":"de Seze","year":"2008","journal-title":"Ann Readapt Med Phys"},{"unstructured":"ANAES. Guide d\u2019analyse de la litt\u00e9rature et gradation des recommandations. Janvier 2000, http:\/\/www.anaes.fr.","key":"10.1016\/j.purol.2009.02.006_bib7"},{"unstructured":"Akbar M, Abel R, Seyler TM, Bedke J, Haferkamp A, Gerner HJ, et al. Repeated botulinum A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.","key":"10.1016\/j.purol.2009.02.006_bib8"},{"key":"10.1016\/j.purol.2009.02.006_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0090-4295(00)00761-5","article-title":"Clinical significance of detrusor sphincter dyssynergia type in patients with post-traumatic spinal cord injury","volume":"56","author":"Weld","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.purol.2009.02.006_bib10","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0022-5347(05)67730-0","article-title":"Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients","volume":"163","author":"Weld","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00365590410015867","article-title":"Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions","volume":"38","author":"Bagi","year":"2004","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.purol.2009.02.006_bib13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200\u00a0cases treated with botulinum A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib15","first-page":"2543","article-title":"Efficacy of botulinum A toxin in adults with neurogenic overactive bladder: initial results","volume":"12","author":"Hajebrahimi","year":"2005","journal-title":"Can J Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib16","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.apmr.2005.06.008","article-title":"Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions","volume":"86","author":"Klaphajone","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.purol.2009.02.006_bib17","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","article-title":"Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity","volume":"68","author":"Karsenty","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.purol.2009.02.006_bib18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.annrmp.2007.03.019","article-title":"Efficacy of repeat injections of botulinum A toxin to the detrusor in neurogenic bladder overactivity","volume":"50","author":"Chenet","year":"2007","journal-title":"Ann Readapt Med Phys"},{"key":"10.1016\/j.purol.2009.02.006_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2007.08.039","article-title":"Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections","volume":"53","author":"Game","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","article-title":"Neurogenic detrusor overactivity treated with english botulinum toxin A: 8-year experience of one single centre","volume":"53","author":"Del Popolo","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.sc.3100432","article-title":"International standards for neurological and functional classification of spinal cord injury","volume":"35","author":"Maynard","year":"1997","journal-title":"Spinal Cord"},{"key":"10.1016\/j.purol.2009.02.006_bib22","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","article-title":"A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum A toxin","volume":"174","author":"Popat","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","article-title":"Single-institution experience in 110\u00a0patients with botulinum toxin A injection into bladder or urethra","volume":"65","author":"Smith","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.purol.2009.02.006_bib24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eururo.2005.12.012","article-title":"Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes","volume":"49","author":"Kalsi","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2005.11.006","article-title":"Cost-consequence analysis evaluating the use of botulinum neurotoxin A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre","volume":"49","author":"Kalsi","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/nau.20153","article-title":"Efficacy of botulinum A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis","volume":"25","author":"Schulte-Baukloh","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.purol.2009.02.006_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eururo.2007.12.029","article-title":"Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity","volume":"54","author":"Kalsi","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-4295(01)01641-7","article-title":"Efficacy of botulinum A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results","volume":"59","author":"Schulte-Baukloh","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.purol.2009.02.006_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","article-title":"Botulinum A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder","volume":"44","author":"Schulte-Baukloh","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib30","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","article-title":"Botulinum A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia","volume":"171","author":"Riccabona","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib31","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.urology.2005.05.054","article-title":"Repeated botulinum A toxin injections in treatment of children with neurogenic detrusor overactivity","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.purol.2009.02.006_bib32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.urology.2006.05.056","article-title":"Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele","volume":"68","author":"Kajbafzadeh","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.purol.2009.02.006_bib33","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-5347(05)00400-3","article-title":"Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele","volume":"175","author":"Altaweel","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib34","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.purol.2009.02.006_bib35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.urology.2005.08.016","article-title":"Therapeutic effects of suburothelial injection of botulinum A toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions","volume":"67","author":"Kuo","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.purol.2009.02.006_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol Urodyn"},{"issue":"suppl. 1","key":"10.1016\/j.purol.2009.02.006_bib37","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.apmr.2006.12.001","article-title":"Spinal cord injury medicine. 1. Epidemiology and classification","volume":"88","author":"Ho","year":"2007","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.purol.2009.02.006_bib38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1166-7087(07)92366-0","article-title":"Continent cutaneous urinary diversion in neurourology","volume":"17","author":"Karsenty","year":"2007","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2009.02.006_bib39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/sj.sc.3102167","article-title":"Treatment of neurogenic bowel dysfunction using transanal irrigation: a multicenter Italian study","volume":"46","author":"Del Popolo","year":"2008","journal-title":"Spinal Cord"},{"key":"10.1016\/j.purol.2009.02.006_bib40","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.juro.2008.08.016","article-title":"Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen","volume":"180","author":"Bonniaud","year":"2008","journal-title":"J Urol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708709000700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708709000700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:16:45Z","timestamp":1761113805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708709000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1166708709000700"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2009.02.006","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crit\u00e8res de d\u00e9cision et recommandations de bonne pratique clinique pour la premi\u00e8re injection intrad\u00e9trusorienne de toxine botulique A dans le traitement de l\u2019hyperactivit\u00e9 neurog\u00e8ne du d\u00e9trusor","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2009.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}